Open Access
RESIDENT’S CORNER
Retroperitoneal Leydig cell tumor recurrence presenting 14 years after orchiectomy
Nicholas H. Chakiryan1, Phil W. Raess2, Kevin Turner2, Jason C. Hedges1, Jen-Jane Liu1
1
Department of Urology, Oregon Health & Science University, Portland, Oregon, USA
2
Department of Pathology, Oregon Health & Science University, Portland, Oregon, USA
Address correspondence to Dr. Nicholas Chakiryan,
Department of Urology, Oregon Health & Science University,
Mail Code CH10U, 3303 SW Bond Avenue, 10th Floor,
Portland, OR 97239 USA
Canadian Journal of Urology 2018, 25(1), 9210-9213.
Abstract
Malignant Leydig cell tumor is a rare entity that has been
previously described as rapidly progressive and uniformly
fatal. We present the case of a malignant Leydig cell
tumor that presented 14 years after orchiectomy with an isolated retroperitoneal metastasis. Our patient
underwent a retroperitoneal lymph node dissection and
has been free of recurrence or progression at 12 months
of follow up. Additionally, we describe the symptomatic
hormone dysfunction experienced by our patient as a
result of his tumor.
Keywords
orchiectomy, malignant Leydig cell tumor, recurrence
Cite This Article
APA Style
Chakiryan, N.H., Raess, P.W., Turner, K., Hedges, J.C., Liu, J. (2018). Retroperitoneal Leydig cell tumor recurrence presenting 14 years after orchiectomy. Canadian Journal of Urology, 25(1), 9210–9213.
Vancouver Style
Chakiryan NH, Raess PW, Turner K, Hedges JC, Liu J. Retroperitoneal Leydig cell tumor recurrence presenting 14 years after orchiectomy. Can J Urology. 2018;25(1):9210–9213.
IEEE Style
N.H. Chakiryan, P.W. Raess, K. Turner, J.C. Hedges, and J. Liu, “Retroperitoneal Leydig cell tumor recurrence presenting 14 years after orchiectomy,” Can. J. Urology, vol. 25, no. 1, pp. 9210–9213, 2018.
Copyright © 2018 The Canadian Journal of Urology.